DuoDecim Evidence-Based Medicine Guidelines - trial access
This content has been modified after the translation.

Dear Users,

 

We would like to inform you about that the Semmelweis University has trial access to DuoDecim Evidence-Based Medicine Guidelines until 12th April. The database contains clinical guidelines to support medical care, linked to the best available evidence. EBMG designed for use at the point of care, the guidelines are delivered in a format that makes it easy for a clinician to make a decision regarding treatment.

 

This Evidence-Based Medicine Guideline collection contains nearly 1,000 concise primary care practice guidelines. It is also supplemented by video guides about clinical examinations and procedures, and also audio samples of heart and lung diseases. It includes high quality photographs of dermatological and ophthalmological anomalies and provides the most important calculators as well.

 

The EBMG is available in Semmelweis University’s network from any computer and by using wifi connection, on mobile devices also (mobile application is not available).